2020 Revenues ($USD) : $8,027,000,000 2020 R&D spend : $425,000,000 2020 Number of Employees : 22,000 Fiscal Year End : 12/31/2020 Key People : Joseph C. Papa, CEO
Bausch Health's Salix segment sells GI products in the United States, while its Ortho Dermatologics segment sells dermatological products in the U.S. and Solta medical aesthetic devices globally. The company's Diversified Products segment in the U.S. sells pharmaceutical products in neurology and other therapeutic classes, generic products, and dentistry products. –CN
Valeant Pharmaceuticals International changed its name to Bausch Health Companies Inc. in 2018.